Home
/
Microbot Medical Inc.
/
Financials
/
Quarterly
Microbot Medical Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Microbot Medical Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Sep 30, 2016
$32.8K
Nov 3, 2016
Q2
2016
Jun 30, 2016
$29.3K
Aug 15, 2016
Q1
2016
Mar 31, 2016
$23.2K
May 10, 2016
Q3
2016
Sep 30, 2015
$37.0K
Nov 3, 2016
Q2
2016
Jun 30, 2015
$30.1K
Aug 15, 2016
Q1
2016
Mar 31, 2015
$21.0K
May 10, 2016
Q3
2015
Sep 30, 2014
$82.4K
Nov 2, 2015
Q2
2014
Jun 30, 2014
$242.2K
Aug 12, 2014
Q1
2015
Mar 31, 2014
$23.6K
May 5, 2015
Q3
2014
Sep 30, 2013
$324.8K
Nov 13, 2014
Q2
2014
Jun 30, 2013
$281.7K
Aug 12, 2014
Q1
2014
Mar 31, 2013
$284.2K
May 14, 2014
Q3
2013
Sep 30, 2012
$264.0K
Nov 5, 2013
Q2
2013
Jun 30, 2012
$248.8K
Aug 7, 2013
Q1
2013
Mar 31, 2012
$644.0K
May 10, 2013
Q3
2012
Sep 30, 2011
$223.6K
Nov 8, 2012
Q2
2012
Jun 30, 2011
$234.1K
Aug 8, 2012
Q1
2012
Mar 31, 2011
$221.5K
May 10, 2012
Q3
2011
Sep 30, 2010
$253.5K
Nov 3, 2011
Q2
2011
Jun 30, 2010
$244.1K
Aug 5, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.58M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($3.50M)
Aug 12, 2025
Q3
2025
Jun 30, 2025
($3.50M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($2.60M)
Aug 12, 2025
Q3
2025
Mar 31, 2025
($2.60M)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($2.60M)
May 14, 2025
Q3
2025
Sep 30, 2024
($3.22M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($2.47M)
Aug 12, 2025
Q3
2025
Jun 30, 2024
($2.47M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($2.37M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($2.37M)
May 14, 2025
Q3
2025
Mar 31, 2024
($2.37M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($2.45M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($2.29M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.29M)
Aug 14, 2024
Q2
2024
Mar 31, 2023
($2.85M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($2.85M)
May 15, 2024
Q3
2024
Mar 31, 2023
($2.85M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($3.47M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($3.51M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.86M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($3.72M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($3.02M)
May 14, 2025
Q3
2025
Sep 30, 2024
($3.30M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($2.51M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($2.38M)
May 14, 2025
Q3
2024
Sep 30, 2023
($2.54M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.32M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($2.92M)
May 15, 2024
Q3
2023
Sep 30, 2022
($3.47M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($3.56M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($3.18M)
May 17, 2023
Q3
2022
Sep 30, 2021
($2.55M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($2.48M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($2.39M)
May 16, 2022
Q3
2021
Sep 30, 2020
($2.42M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.88M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($2.16M)
May 17, 2021
Q3
2020
Sep 30, 2019
($1.79M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($1.55M)
Aug 14, 2020